Advanced Dry Eye Clinic at The Eyesmith

Advanced Biomarker Testing (Seinda i-ImmunDx)

Understanding why your eyes are dry

Traditional dry eye testing shows us what is happening on the surface of your eyes.

Biomarker testing goes one step further — it shows us what is causing it at a molecular level.

Using the Seinda i‑ImmunDx Analyzer, we can identify the type of inflammation driving your condition and tailor treatment accordingly.

Why this matters

Many patients are told they “have dry eye” — but dry eye is not one condition.

It can be:

  • Inflammatory

  • Allergic

  • Immune-driven

  • Or a combination

By identifying the underlying mechanism, we can move away from trial-and-error and deliver targeted, personalised treatment.

The 3 Key Biomarkers We Measure

1. MMP-9 — Inflammation Marker

This marker tells us if there is active inflammation on the surface of the eye.

What it means for you:

  • Often linked to classic dry eye (MGD or tear deficiency)

  • Causes irritation, redness, and unstable tears

How it guides treatment:

  • Anti-inflammatory therapies

  • IPL to reduce inflammation

  • Support for tear film stability

2. IgE — Allergy Marker

This identifies whether allergy is contributing to your symptoms.

What it means for you:

  • Itching, irritation, and watery eyes

  • Symptoms may worsen seasonally

  • Can mimic or overlap with dry eye

How it guides treatment:

  • Targeted anti-allergy treatment

  • Avoids unnecessary over-treatment with steroids

  • Helps separate true dry eye from allergic eye disease

3. LTA (Lymphotoxin-α) — Chronic Immune Marker

This marker indicates long-standing or immune-driven inflammation.

What it means for you:

  • More persistent or treatment-resistant dry eye

  • Often associated with chronic irritation

How it guides treatment:

  • Earlier use of advanced therapies

  • Longer-term treatment strategies

  • More proactive management

Identifying Mixed Conditions

Many patients don’t have just one cause.

For example:

  • Dry eye symptoms + seasonal irritation

Without biomarkers → “dry eye”

With biomarker testing →
Dry eye + allergy overlap

Why this is important

Different causes require different treatments.

By identifying overlaps, we can:

  • Combine treatments more effectively

  • Avoid unnecessary medication

  • Achieve better, faster results

From General Diagnosis to Precision Care

Traditional approach

  • Based on symptoms and surface signs

  • Often involves trial and error

Biomarker-led approach

  • Identifies the underlying cause

  • Guides targeted treatment

  • Tracks response over time

Tracking Your Progress

Biomarkers also allow us to monitor how well treatment is working.

For example:

  • Inflammation levels reducing after treatment

  • Objective proof of improvement

  • Greater confidence in long-term management

How this fits into your treatment

Your biomarker results directly guide your care pathway:

  • Inflammation present → IPL + anti-inflammatory treatment

  • Blocked glands → IPL + Expression + QMR

  • Allergy component → targeted allergy treatment added

  • Chronic immune pattern → earlier escalation and long-term strategy

Why this is different

The Seinda i‑ImmunDx Analyzer does not replace traditional testing — it enhances it.

It allows us to understand:

👉 Not just that your eyes are dry — but why

The Result

A more precise diagnosis leads to:

  • More effective treatment

  • Faster symptom relief

  • Better long-term control

Clinical Advantage

This level of testing allows us to:

  • Reduce trial-and-error treatment

  • Justify advanced therapies such as IPL and QMR

  • Deliver a truly personalised dry eye treatment plan

Next Step

Book your Advanced Dry Eye Assessment to understand the cause of your symptoms and explore your treatment options.